143 related articles for article (PubMed ID: 10516262)
1. Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents.
Faden AI; Fox GB; Fan L; Araldi GL; Qiao L; Wang S; Kozikowski AP
Am J Physiol; 1999 Oct; 277(4):R1196-204. PubMed ID: 10516262
[TBL] [Abstract][Full Text] [Related]
2. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo.
Faden AI; Knoblach SM; Cernak I; Fan L; Vink R; Araldi GL; Fricke ST; Roth BL; Kozikowski AP
J Cereb Blood Flow Metab; 2003 Mar; 23(3):342-54. PubMed ID: 12621309
[TBL] [Abstract][Full Text] [Related]
3. Imidazole-substituted analogues of TRH limit behavioral deficits after experimental brain trauma.
Faden AI; Labroo VM; Cohen LA
J Neurotrauma; 1993; 10(2):101-8. PubMed ID: 8411214
[TBL] [Abstract][Full Text] [Related]
4. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
Faden AI
Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice.
Faden AI; Fox GB; Di X; Knoblach SM; Cernak I; Mullins P; Nikolaeva M; Kozikowski AP
J Cereb Blood Flow Metab; 2003 Mar; 23(3):355-63. PubMed ID: 12621310
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.
McIntosh TK; Fernyak S; Hayes RL; Faden AI
J Neurotrauma; 1993; 10(4):373-84. PubMed ID: 8145261
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of novel small peptides in vitro and after brain injury.
Faden AI; Movsesyan VA; Knoblach SM; Ahmed F; Cernak I
Neuropharmacology; 2005 Sep; 49(3):410-24. PubMed ID: 15907950
[TBL] [Abstract][Full Text] [Related]
8. The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.
Keck CA; Thompson HJ; Pitkänen A; LeBold DG; Morales DM; Plevy JB; Puri R; Zhao B; Dichter M; McIntosh TK
Restor Neurol Neurosci; 2007; 25(2):77-90. PubMed ID: 17726266
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new analogue of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents.
Yamamoto M; Shimizu M
Neuropharmacology; 1989 Aug; 28(8):863-6. PubMed ID: 2506487
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
Shimizu M; Yamamoto M; Kobayashi M
Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
[TBL] [Abstract][Full Text] [Related]
11. Novel small peptides with neuroprotective and nootropic properties.
Faden AI; Knoblach SM; Movsesyan VA; Cernak I
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S93-7. PubMed ID: 15665420
[TBL] [Abstract][Full Text] [Related]
12. Effects of YM-14673, a new TRH analogue, on neurological deficits in rats with experimental cerebral hematoma.
Yamamoto M; Shimizu M; Kawabata S; Terai M
Arch Int Pharmacodyn Ther; 1989; 299():55-64. PubMed ID: 2505700
[TBL] [Abstract][Full Text] [Related]
13. Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents.
Yamamoto M; Ozawa Y; Sasamata M; Koshikawa N; Kobayashi M
Eur J Pharmacol; 1990 May; 180(2-3):319-24. PubMed ID: 1973117
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
[TBL] [Abstract][Full Text] [Related]
15. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673.
Behrmann DL; Bresnahan JC; Beattie MS
Exp Neurol; 1994 Mar; 126(1):61-75. PubMed ID: 8157127
[TBL] [Abstract][Full Text] [Related]
16. Novel neuroprotective tripeptides and dipeptides.
Faden AI; Knoblach SM; Movsesyan VA; Lea PM; Cernak I
Ann N Y Acad Sci; 2005 Aug; 1053():472-81. PubMed ID: 16179555
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of TRH analogs in rat spinal cord injury.
Faden AI; Sacksen I; Noble LJ
Brain Res; 1988 May; 448(2):287-93. PubMed ID: 3132308
[TBL] [Abstract][Full Text] [Related]
18. A novel analog of TRH, YM14673, causes a decrease in brain TRH receptors in vitro.
Monden T; Mizuma H; Yamada M; Murakami M; Mori M
Endocr Res; 1995 Nov; 21(4):803-14. PubMed ID: 8582330
[TBL] [Abstract][Full Text] [Related]
19. Effects of YM-14673, a new TRH analogue, on behavioral and electrophysiological changes in rats subjected to electrical lesion of the internal capsule.
Yamamoto M; Shimizu-Sasamata M; Kawabata S; Terai M
Arch Int Pharmacodyn Ther; 1990; 306():5-17. PubMed ID: 2127525
[TBL] [Abstract][Full Text] [Related]
20. Effects of YM-14673, a new TRH analogue, on responses to morphine in rodents.
Yamamoto M; Shimizu M; Ozawa Y
Arch Int Pharmacodyn Ther; 1989; 300():29-36. PubMed ID: 2515820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
